Latest Breaking News On - Nasdaq stock market of the company - Page 1 : vimarsana.com

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, May 03, 2024 NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of.

United statesNoord hollandMatthew philippeCompany contactNewamsterdam pharma companyCompensation committee of newamsterdam board directorsNewamsterdam pharma companynv nasdaqNasdaq stock market of the companyCompensation committeeNasdaq listing ruleNasdaq stock marketAmsterdam pharma

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, May 03, 2024 (GLOBE NEWSWIRE) NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin

United statesNoord hollandMatthew philippeCompensation committee of newamsterdam board directorsNewamsterdam pharma companynv nasdaqNewamsterdam pharma companyNasdaq stock market of the companyCompany contactCompensation committeeNasdaq listing ruleNasdaq stock marketAmsterdam pharma

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

Phaxiam Therapeutics S A : PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomPherecydes pharmaArthur rouillEric soyerPharma bioEnregistrement universelCompany adssExchange commissionCompany annual report on formSecurities exchangeNasdaq stock market of the companyCompany securitiesAmerican depositary sharesNasdaq capital

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketPHAXIAM remains listed on Eu.

France generalUnited kingdomUnited statesNew yorkArthur rouillPharma bioEnregistrement universelPherecydes pharmaEric soyerCompany annual report on formNasdaq stock market of the companyCompany adssCompany securitiesSecurities exchangeReceipt administrationExchange commission

Investegate | Company Announcement

Investegate announcements from PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

United kingdomFrance generalUnited statesNew yorkEric soyerPherecydes pharmaPharma bioEnregistrement universelArthur rouillCompany securitiesCompany adssExchange commissionNasdaq stock market of the companySecurities exchangeAdss for the companyCompany annual report on form